Similar articles

• Outcomes of primary angle closure glaucoma management.

  Alipanahi R, Sayyahmelli S. Alipanahi R, et al. J Pak Med Assoc. 2011 Jul;61(7):636-9. J Pak Med Assoc. 2011. PMID: 22204235
• Prevention of angle-closure glaucoma: balancing risk and benefit.

  Foster PJ, Ng WS, Nolan WP, Tanner L, Gazzard G, Day AC, Sanders R, Foot B, Salmon JF, Azuara-Blanco A. Foster PJ, et al. Eye (Lond). 2022 Dec;36(12):2229-2231. doi: 10.1038/s41433-021-01881-8. Epub 2022 Jun 20. Eye (Lond). 2022. PMID: 35725765 Free PMC article. No abstract available.
• Acute primary angle closure in an Asian population: long-term outcome of the fellow eye after prophylactic laser peripheral iridotomy.

  Ang LP, Aung T, Chew PT. Ang LP, et al. Ophthalmology. 2000 Nov;107(11):2092-6. doi: 10.1016/s0161-6420(00)00360-2. Ophthalmology. 2000. PMID: 11054339
• Role of phacoemulsification in angle closure glaucoma.

  Moghimi S, Lin S. Moghimi S, et al. Eye Sci. 2011 Sep;26(3):121-31. doi: 10.3969/j.issn.1000-4432.2011.03.001. Eye Sci. 2011. PMID: 21913342 Review.
• [Acute angle closure and angle closure glaucoma: Phacoemulsification as first-line treatment].

  Lachkar Y. Lachkar Y. J Fr Ophtalmol. 2010 Apr;33(4):273-8. doi: 10.1016/j.jfo.2010.02.009. Epub 2010 Mar 26. J Fr Ophtalmol. 2010. PMID: 20347182 Review. French.